Amy Hakim

1.4k total citations
22 papers, 957 citations indexed

About

Amy Hakim is a scholar working on Reproductive Medicine, Surgery and Oncology. According to data from OpenAlex, Amy Hakim has authored 22 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 8 papers in Surgery and 8 papers in Oncology. Recurrent topics in Amy Hakim's work include Ovarian cancer diagnosis and treatment (10 papers), Intraperitoneal and Appendiceal Malignancies (7 papers) and Cervical Cancer and HPV Research (5 papers). Amy Hakim is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Intraperitoneal and Appendiceal Malignancies (7 papers) and Cervical Cancer and HPV Research (5 papers). Amy Hakim collaborates with scholars based in United States and Malaysia. Amy Hakim's co-authors include Katsuhiko Yano, Beatriz L. Rodríguez, G. Webster Ross, Robert D. Abbott, Lon R. White, Helen Petrovitch, Cecil M. Burchfiel, J. David Curb, J. David Curb and Mark T. Wakabayashi and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Amy Hakim

21 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Hakim United States 11 333 222 181 170 142 22 957
Catherine Allen United States 18 334 1.0× 325 1.5× 186 1.0× 47 0.3× 235 1.7× 29 2.1k
Sabine Schipf Germany 25 260 0.8× 293 1.3× 317 1.8× 32 0.2× 160 1.1× 79 1.8k
John A. Linton South Korea 22 229 0.7× 237 1.1× 136 0.8× 19 0.1× 160 1.1× 55 1.2k
B. K. Jacobsen Norway 9 162 0.5× 258 1.2× 183 1.0× 17 0.1× 122 0.9× 10 1.3k
Sireesha Reddy United States 17 136 0.4× 241 1.1× 109 0.6× 20 0.1× 86 0.6× 38 1.2k
Sharon Torres United States 6 244 0.7× 216 1.0× 161 0.9× 34 0.2× 108 0.8× 8 1.1k
Walter F. DeNino United States 16 447 1.3× 302 1.4× 258 1.4× 89 0.5× 194 1.4× 32 1.1k
B. M. Makkar India 6 221 0.7× 225 1.0× 156 0.9× 21 0.1× 143 1.0× 13 1.1k
Ilona Csizmadi Canada 21 429 1.3× 556 2.5× 46 0.3× 34 0.2× 45 0.3× 54 1.2k
Y P Munjal India 5 197 0.6× 226 1.0× 209 1.2× 23 0.1× 141 1.0× 7 1.0k

Countries citing papers authored by Amy Hakim

Since Specialization
Citations

This map shows the geographic impact of Amy Hakim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Hakim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Hakim more than expected).

Fields of papers citing papers by Amy Hakim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Hakim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Hakim. The network helps show where Amy Hakim may publish in the future.

Co-authorship network of co-authors of Amy Hakim

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Hakim. A scholar is included among the top collaborators of Amy Hakim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Hakim. Amy Hakim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Dellinger, Thanh H., Ernest Han, Wei-Chien Lin, et al.. (2021). Safety and tolerability of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in ovarian cancer: clinical results from a phase I trial. Gynecologic Oncology. 162. S269–S269. 2 indexed citations
4.
Cristea, Mihaela, Paul Frankel, Timothy W. Synold, et al.. (2020). 863P A phase I study of mirvetuximab soravtansine (MIRV) and gemcitabine (G) in pts with selected FRα -positive solid tumours: Results in the endometrial cancer (EC) cohort. Annals of Oncology. 31. S639–S639. 1 indexed citations
5.
Cristea, Mihaela, Paul Frankel, Timothy W. Synold, et al.. (2019). A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity. Cancer Chemotherapy and Pharmacology. 83(3). 589–598. 25 indexed citations
6.
Cristea, Mihaela, Paul Frankel, Timothy W. Synold, et al.. (2019). A phase I study of mirvetuximab soravtansine (IMGN853) and gemcitabine (G) in patients with FOLR1-positive recurrent epithelial ovarian (EOC), endometrial cancer (EC), or triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 37(15_suppl). 3009–3009. 1 indexed citations
7.
Hakim, Amy, et al.. (2016). Teachers' Perceptions of Principals as Instructional Leaders and Student Academic Achievement in Elementary Schools. Journal of Marketing Management. 7(1). 1.
8.
Dellinger, Thanh H., Amy Hakim, Stephen J. Lee, et al.. (2016). Surgical Management of Vulvar Cancer. Journal of the National Comprehensive Cancer Network. 15(1). 121–128. 39 indexed citations
9.
Cristea, Mihaela, Timothy W. Synold, Paul Frankel, et al.. (2015). Pharmacologic advantage (PA) of intraperitoneal (IP) nab-paclitaxel in patients with advanced malignancies primarily confined to the peritoneal cavity.. Journal of Clinical Oncology. 33(15_suppl). 2553–2553. 10 indexed citations
10.
Cristea, Mihaela, Saul E. Rivkin, Dean Lim, et al.. (2014). Phase I Trial of Intraperitoneal Nab-Paclitaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity. Annals of Oncology. 25. iv159–iv159. 3 indexed citations
11.
Sun, Virginia, Shirley Otis‐Green, Robert J. Morgan, et al.. (2012). Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer. European Journal of Oncology Nursing. 17(3). 375–380. 8 indexed citations
12.
Otis‐Green, Shirley, Mark T. Wakabayashi, Robert J. Morgan, et al.. (2012). Palliative Care Opportunities for Women with Advanced Ovarian Cancer Associated with Intraperitoneal Chemotherapy. Journal of Palliative Medicine. 16(1). 44–53. 3 indexed citations
13.
Hakim, Amy, H. John Barnes, Kenneth E. Anderson, et al.. (2009). Ovarian Adenocarcinomas in the Laying Hen and Women Share Similar Alterations in p53, ras, and HER-2/neu. Cancer Prevention Research. 2(2). 114–121. 65 indexed citations
14.
Hakim, Amy & Tri A. Dinh. (2009). Worldwide Impact of the Human Papillomavirus Vaccine. Current Treatment Options in Oncology. 10(1-2). 44–53. 25 indexed citations
15.
Hakim, Amy, et al.. (2007). Indications and Efficacy of the Human Papillomavirus Vaccine. Current Treatment Options in Oncology. 8(6). 393–401. 9 indexed citations
16.
Hakim, Amy & Keith Y. Terada. (2006). Sentinel node dissection in vulvar cancer. Current Treatment Options in Oncology. 7(2). 85–91. 15 indexed citations
17.
Hakim, Amy, J. David Curb, Helen Petrovitch, et al.. (1999). Effects of Walking on Coronary Heart Disease in Elderly Men. Circulation. 100(1). 9–13. 202 indexed citations
18.
Hakim, Amy, Helen Petrovitch, Cecil M. Burchfiel, et al.. (1998). Effects of Walking on Mortality among Nonsmoking Retired Men. New England Journal of Medicine. 338(2). 94–99. 412 indexed citations
19.
Hakim, Amy, G. Webster Ross, J. David Curb, et al.. (1998). Coffee Consumption in Hypertensive Men in Older Middle-Age and the Risk of Stroke. Journal of Clinical Epidemiology. 51(6). 487–494. 40 indexed citations
20.
Abbott, Robert D., Dan S. Sharp, Cecil M. Burchfiel, et al.. (1997). Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: The Honolulu heart program. Annals of Epidemiology. 7(6). 417–424. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Allen Breakdown of academic impact, for papers by Sabine Schipf Breakdown of academic impact, for papers by John A. Linton Breakdown of academic impact, for papers by B. K. Jacobsen Breakdown of academic impact, for papers by Sireesha Reddy Breakdown of academic impact, for papers by Sharon Torres Breakdown of academic impact, for papers by Walter F. DeNino Breakdown of academic impact, for papers by B. M. Makkar Breakdown of academic impact, for papers by Ilona Csizmadi Breakdown of academic impact, for papers by Y P Munjal
Rankless by CCL
2026